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Abstract
Background: During early rat pregnancy, trophoblast of the tiny embryo joins with the endometrium and
epithelial cells undergo apoptosis. Near the end of pregnancy, regression of the decidua basalis (DB) is also
observed (from day 14 to 20). However, little is known about the intra-cellular and molecular mechanisms
involved in apoptosis regulation in the uterus during pregnancy. The objective of the present study was to
investigate the presence and the developmental expression of transforming growth factor-beta isoforms (TGF-
beta well known differentiation factor) in the rat endometrium throughout pregnancy and its action in vitro using
cultured endometrial stromal cells.
Methods: In vivo: Rats were killed at different days of pregnancy (days 2–20) and uteri removed to collect
endometrial protein extracts or the uteri were fixed, embedded and sectioned for immunohistochemistry (IHC)
and in situ cell death analyses using TdT-mediated dUTP nick end labeling (TUNEL). In vitro: Rats were
ovariectomized and decidualization was induced using sex steroids. Endometrial stromal decidual cells were then
collected and cultured.
Results: An increase of apoptosis in the DB on days 14, 16 and 18 was observed. Cleaved caspase-3 was clearly
detected during regression of the DB by Western analysis and immunofluorescence. Western analyses using
endometrial protein extracts demonstrated that TGF-beta1, TGF-beta2 and TGF-beta3 were highly expressed at
the time of DB regression (day 14). During early pregnancy, TGF-beta1 and -beta2 expressions raised at days 5.5
to 6.5. TGF-beta3 protein was not detected during early pregnancy. IHC analyses revealed that TGF-beta1 and -
2 were found surrounding both epithelium (luminal and glandular) in the stroma compartment at the implantation
site, and TGF-beta3 was mainly located surrounding endometrial epithelium in the stroma compartment. Smad2
phosphorylation was increased at the time of DB regression. In vitro studies using decidual endometrial stromal
cells revealed that TGF-beta1 induced apoptosis and Smad2 phosphorylation. Moreover, TGF-beta1 reduced both
Akt (a well known survival factor) phosphorylation and XIAP (X-linked inhibitor of apoptosis protein) expression
in decidual endometrial stromal cells in vitro.
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Conclusion: Taken together, these results suggest that TGF-beta isoforms are regulated differently during
pregnancy and may have an important role in the control of apoptosis and cell survival at specific stages during
pregnancy.
Background
Apoptosis is a type of programmed cell death and is a nat-
ural phenomenon occurring when the cells are subjected
to stress such as DNA damage, death signals or lack of
growth factor. Apoptotic stimuli allow an intracellular
cascade of signals such as the caspases, a family of cysteine
proteases implicated in the cleavage of a number of
important proteins which results in cell disassembly and
cell death, phagocytosis and removal of cell debris by
immune cells. Apoptosis plays an important role during
embryo implantation in rodents where morphological
characteristics of apoptosis are observed in endometrial
epithelial cells at the embryo implantation site [1-3].
Moreover, this phenomenon also occurs during late preg-
nancy, especially during regression of the decidua basalis
(DB) in the rat endometrium [4,5]. Two decidual zones
are formed during pregnancy: the primary decidual zone
on the antimesometrial side of the uterus and the second-
ary decidual zone (or antimesometrial decidua) which is
formed following expansion of the primary decidual zone
[5,6]. The secondary decidual zone eventually transforms
stromal cells in the mesometrial region to form the DB
that regresses following day 14 of pregnancy [7]. Whether
the phenomenon of growing size of embryo is a cause or
correlation to the increase of apoptosis remains to be
elucidated.
The first members of the transforming growth factor-beta
(TGF-β ) superfamily were identified on the basis of their
ability to induce a transformed phenotype of certain cells
in culture [8]. They are now known as multifunctional
polypeptides involved in the regulation of cell prolifera-
tion and differentiation, immunoregulation, angiogenesis
and the regulation of extracellular matrix [9,10]. They act
via cellular signalling through Smads and Phosphor-
ylated-Smads (P-Smads), the active form of Smads. Those
proteins are translocated to the nucleus and activate tran-
scription factors which in turn activate caspases and other
regulation proteins [11,12]. Another characteristic of TGF-
β  is its capacity to induce apoptosis in several cell types
[7,13]; in fact, TGF-β  was shown to have a pro-apoptotic
function mediated by caspases [14-16]. Genes encoding
the three isoforms are localized on different chromo-
somes and the isoforms molecular weights are slightly dif-
ferent: 15, 12.5 and 12 KDa for TGF-β 1,  β 2 and β 3
respectively; they share 80 % sequence identity and are
produced in latent forms which are activated into a 112-
amino acid mature peptide [17]. Multiplicity of TGF-β  iso-
forms and sequence conservation within each form
through evolution suggests important specific roles.
Moreover, it has been demonstrated that TGF-β 1, -β 2 and
-β 3 are differently expressed in the mouse uterus [18] and
porcine conceptus-maternal interface [19,20].
The uterus is a hormone-dependent organ and it is subject
to an abundant amount of cellular proliferation and cell
death. Studies have shown that apoptosis is increased in
the rat endometrium during implantation and regression
of the decidual basalis in the rat [1,2,21]. The mRNA for
TGF-β 1 has been shown to be present within the uterus
during rat pregnancy and was localized to the luminal and
glandular epithelial cells during early and late pregnancy
[22]. TGF-β 1 and -β 2 mRNAs were also found in the
mouse uterus during pregnancy [23-25]. Expression of
TGF-β 2 and TGF-β 3 mRNAs were also shown to be
expressed in the mouse periimplantation uterus [18]. A
study showed that TGF-β 1 and -β 2 treatments on cultured
endometrial rat stromal cells induced apoptosis [7]. These
studies suggest that TGF-β  isoforms might be involved
specifically in the control of apoptosis in the uterus during
pregnancy. However, the mechanisms involved in the
control of apoptosis in the endometrium during preg-
nancy are poorly documented. Studies suggesting the
importance of TGF-β  isoforms at specific time of preg-
nancy were done at the mRNA level and it is important to
determine their presence at the protein level. Thus, the
aim of this study was to determine the expression and the
developmental expression of TGF-β 1, β 2 and β 3 proteins
in the rat uterus throughout pregnancy and to further
determine  in vitro, the effect of TGF-β  in determining
decidual cell fate. We found that the three isoforms of
TGF-β  were expressed and regulated differently in epithe-
lial and stromal endometrial cells during rat pregnancy
and showed using primary decidual cell cultures the
involvement of TGF-β  in the regulation of programmed
cell death. Moreover, the present study shows that TGF-β
signals through Smad2, which coincide with XIAP and Akt
down regulation and induction of apoptosis.
Methods
Reagents
TGF-β 1 (sc-146, lot # F262, 200 µg/ml), TGF-β 2 (sc-90,
lot # B202, 200 µg/ml) and TGF-β 3 (sc-82, lot # A222,
200 µg/ml) polyclonal antibodies were purchased from
Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA).
CDC47/MCM7 antibody was obtained from Medicorp
(Montréal, QC, Canada). Phospho-Akt (Ser 473), Akt,
XIAP, Cleaved caspase-3, and Phospho-Smad2 (Ser 465 /Reproductive Biology and Endocrinology 2005, 3:20 http://www.rbej.com/content/3/1/20
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467) antibodies were obtained from Cell Signaling Tech-
nology (Beverly, MA, USA). The Keratin 8/18 antibody
used to determine cell culture purity was donated by Dr
Monique Cadrin (Univ. of Québec at Trois-Rivières, QC,
Canada). Anti-Smad2/3 antibody was purchased from
Calbiochem (San Diego, CA, USA). Vectastain ABC Kit for
rabbit IgG was purchased from Vector Laboratories Inc.
(Burlingame, CA, USA). In Situ Cell Death detection kit
(TUNEL), POD and DAB substrate was obtained from
Roche (Laval, QC, Canada). TGF-β 1 recombinant protein
was purchased from Biosource (Cat # PHG9104, lot #
16865-01S, 5 µg, diluted at 50 µg/ml, QC, Canada).
Animals
Sprague-Dawley female rats, 200–225 g, were obtained
from Charles River Laboratories Canada. Animals were
maintained on standard chow and water, which were
available  ad libitum, in animal facilities illuminated
between 6:00 h and 20:00 h. All procedures were per-
formed in accordance with guidelines of the Canadian
Council on Animal Care for the handling and training of
laboratory animals and the Good Health and Animal Care
Committee of the Université du Québec à Trois-Rivières.
Male and female mice were mated overnight and confir-
mation of pregnancy was determined by vaginal smears
and/or the presence of a vaginal plug (day 1). Rats were
killed on day 2, 4, 5, 6, 8, 10, 12, 14, 16, 18 and 20 of
pregnancy at 10:00 h in the morning and at 18:00 h for
days 5.5 and 6.5. Six to 8 different rats were used for each
time of pregnancy. Uteri were collected and fixed for
immunohistochemical staining (IHC) and apoptotic cell
death detection by [TdT]-mediated deoxyuridinetriphos-
phate nick end-labeling (TUNEL) or endometrial protein
extracts collected for Western blot analysis.
Rat pretreatments and decidual endometrial stromal cell 
culture
A total of 10 rats were ovariectomized and then allowed
to recover from surgery for a minimum of 10 days. They
were pre-treated with physiological doses of estradiol
(1,3,5(10)-Estratriene-3,17β -diol, Sigma-aldrich) and
progesterone (Laboratoire Mat, PQ) to induce deciduali-
zation as described previously [26]: 1) 0.2 ug estradiol
injection per day for three days (in the morning, day -2,-1
and 0); 2) On the third day (day 0 of pseudopregnancy),
another injection in the afternoon of estradiol (0.2 µg)
and progesterone (1 mg) was performed; 3) No treatment
for 2 days (day 1 and 2 of pseudopregnancy); 4) Injections
of estradiol (0.1 µg) and progesterone (4 mg) for three
days (day 3, 4 and 5 of pseudopregnancy); 5) Another
injection of estradiol (0.1 µg) in the afternoon on day 7
(day 4 of pseudopregnancy); 6) Rats were killed on day 8
(day 5 of pseudopregnancy). All endometrial stromal cells
collected for cultures were recovered from rats treated
with the protocol described above.
Uteri were removed and horns taken and immerged in
HBSS solution containing HEPES (20 mM), penicillin
(100 units/ml), streptomycin (100 µg/ml) and fungizone
(1,25 µl/ml) (Invitrogen, ON, Canada). Further manipu-
lations were performed in a sterile environment. The uter-
ine horns were transferred into a sterile petri containing
HBSS, slit longitudinally and immersed in trypsin type I
solution (0.3%) (Roche Diagnostics, QC, Canada) in
HBSS and agitated for 60 minutes at room temperature.
Uterine horns were then vortexed at maximum for 5 sec
and supernatant containing epithelial cells was discarded.
Uterine horns were washed three times with 2.5 ml of
HBSS and immersed in a HBSS solution containing
trypsin type I (0.03%), DNAse I (0.016%) and colla-
genase type II (0.064%) for 15 minutes at 37°C in a water
bath. Uterine horns were then vortexed at maximum for 5
sec. The supernatant containing stromal cells was trans-
ferred into a sterile falcon tube containing 150 µl of FBS
D.C (Dextran-Charcoal extracted). Uterine horns were
washed two times with 2.5 ml of HBSS and the superna-
tant was mixed with stromal cells. Uterine horns were dis-
carded and stromal cells were centrifuged at 1000 g for 5
minutes. Cells were washed two times with HBSS and cen-
trifuged. The supernatant was discarded and cells diluted
with DMEM-F12 (Ph 7.1) (Invitrogen, ON, Canada) con-
taining 2.438 g/L NaHCO3, 10% FBS D.C. and gentamy-
cine 50 µg/ml. Cells were incubated at 37°C in an
atmosphere of 5% CO2. Cells were plated in 6-well plates
(Corning plates) at a density of 50% (4 × 105 cells per
well). The medium was changed two hours after the first
incubation in order to eliminate epithelial cell contami-
nation from stromal cell cultures. The purity of stromal
cells was more than 97%: cell culture contamination with
epithelial cells was evaluated by cellular morphology and
immunofluorescence using a Keratin 8/18 antibody.
Three to 5 days after plating (more than 90% of conflu-
ency reached), cells were treated for 24 hours in the pres-
ence or absence of increasing doses of TGF-β  recombinant
protein. Total proteins from treated cell cultures were
extracted using TRIZOL (Invitrogen, ON, Canada). For
Western blot analyses, 15 µg of total protein was used for
each analysis.
Immunohistochemical staining
The uterus was fixed in 4% paraformaldehyde solution
and embedded in paraffin. Tissue sections 7 µm thick
were mounted on polylysine-coated slides, deparaffin-
ized, rehydrated, and then heated in 10 mM citrate buffer
(pH 6) containing triton X-100 (Sigma-Aldrich) 0.1% (v/
v). After two washes with PBS, slides were then incubated
with 0.3 % hydrogen peroxide in methanol for 30 min to
quench endogenous peroxidase activity. After washing
with PBS, tissues were incubated with blocking serum
(Vectastain ABC Kit) at room temperature for 1 h. Then, a
primary antibody diluted in blocking serum (TGF-β 1, β 2Reproductive Biology and Endocrinology 2005, 3:20 http://www.rbej.com/content/3/1/20
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or β 3; 1:50 dilution or CDC47/MCM7; 1:100 dilution)
was added to the slides and incubated at 4°C overnight in
a humidified chamber. After washing 5 min. in PBS, tissue
sections were incubated for 30 min. with 3 µg/ml bioti-
nylated antibody (anti-rabbit or anti-mouse). Subse-
quently, slides were washed with PBS and incubated with
avidin-biotin complex reagent containing horseradish
peroxidase for 30 min. Slides were washed with PBS for 5
min and color development was achieved using DAB sub-
strate. The tissue sections were counterstained with hae-
matoxylin. Negative controls were performed using the
same protocol but substituting the primary antibody with
normal rabbit IgG (Vector Laboratories Inc., Burlingame,
CA, USA).
Immunofluorescence
Tissues were prepared as described in the immunohisto-
chemical section. Cleaved caspase-3 antibody was diluted
1:100 in blocking serum and slides were incubated at 4°C
overnight. After washing twice for 5 min. in PBS, tissue
sections were incubated for 30 min. at room temperature
with 2 mg/ml Alexa Fluor 488 donkey anti-rabbit (1:50).
Subsequently, slides were washed with PBS and mounted.
Negative controls were performed using the same proto-
col but substituting the primary antibody with normal
rabbit IgG. Sections were examined using an
OlympusBX60 microscope equipped with a Coolsnap-
pro CF digital camera (Carsen Group, ON, Canada).
TdT-mediated deoxyuridinetriphosphate nick end-labeling 
(TUNEL)
Tissue sections were deparaffinized, rehydrated and rinsed
with PBS. They were incubated with proteinase K (20 µg/
ml) for 30 min. at room temperature. Slides were washed
twice with PBS, the endogenous peroxidase was quenched
with 0.3 % hydrogen peroxide in methanol for 30 min.
The slides were rinsed and incubated with 10 mM citrate
solution for two min on ice. Then, tissue sections were
rinsed with PBS and incubated with TdT labelling reaction
(In Situ Cell Death Detection, POD) for 30 min at 37°C
in humidified environment. Slides were washed three
times in PBS and tissue sections were blocked with 3%
BSA for 20 min. at room temperature. Converter-POD
solution was added to the slides and incubated for 30
min. at 37°C in humidified environment. Slides were
washed for 5 min. in PBS, colour development was
achieved using DAB substrate and counterstained with
haematoxylin. Negative controls were performed using
the same protocol without TdT enzyme.
Protein extraction and Western analysis
Protein homogenates from pregnant endometrium were
isolated according to a protocol previously described [27].
Briefly, uteri from Day 2 to Day 20 pregnant rats were rap-
idly excisedand placed in ice-cold saline until dissected.
Uteri were carefully laid on a glass plate and placed on the
stage of a dissecting microscope. In early pregnancy (Day
2 to 5.5), total endometrium was scraped using a micro-
scope glass and collected. Uteri from Day 6 to 10 the pla-
centa and decidua were at an early stage of differentiation
and could not be reliably separated. For this reason, DB
dissectedfrom animals between these days of pregnancy
contain some chorioallantoic cells, but antimesometrial
decidua, choriovitelline tissues, fetus, and myometrium
were removed. Even though we carefully dissected DB
from these tissues, it is a possibility that a contamination
with some antimesometrial decidual cells that regress to
form the deciduas caspularis (DC) would occur. This is an
important fact that we need to take into consideration. In
uteri collected from Day 12 to 20 pregnant rats, DB were
isolated by gently separating the placenta and myometrial
regions with 23-gauge needles. Additionally, the DB
began to regress on Day 14 and became too thin to relia-
blydissect after Day 17. The protocol for DB isolation was
described previously by Ogle and George [28].
Endometrial cells from pregnant animals were homoge-
nized using a pipette in RIPA lysis buffer (PBS 1× pH 7.4;
1% Nonidet P-40; 0.5% Sodium deoxycholate; 0.1% SDS;
Protease Inhibitor Cocktail Tablets (Roche Diagnostics
Canada, PQ)). Homogenates were centrifuged (12,000 ×
g for 20 min at 4°C) to remove insoluble material. The
supernatant was recovered and stored at -20°C pending
analysis. Protein content was determined with the Bio-
Rad DC Protein Assay. Protein extracts (50 µg) were
heated at 94°C for 3 min, resolved by 10% SDS-PAGE and
electrotransferred to nitrocellulose membranes using a
semidry transfer (Bio-Rad, Mississauga, ON). The mem-
branes were then blocked 2 h at room temperature with
PBS containing 5 % milk powder, then incubated with
anti TGF-β  1-2-3 1:1000 ; P-Smad2 (Ser 465 / 467) 1:1000
and Smad 2/3 1:1000 and subsequently with horseradish
peroxidase-conjugated anti-rabbit or anti-mouse second-
ary antibody (1:3000; room temperature for 45 min). All
membranes were stripped with Restore western blot strip-
ping buffer (Pierce, # 21059, lot # FH71541), reprobed
with an antibody specific to β -actin which was used as an
internal standard. Peroxidase activity was visualized with
the Super signal® West Femto maximum sensitivity sub-
strate (Pierce, Arlington Heights, IL, USA), according to
the manufacturer's instructions. Signal was visualized
using the Biochemi Imaging System (UVP, CA, USA).
Densitometrical analyses were performed (protein of
interest and β -actin) using the GelDoc 2000 and the
Quantity One software (Bio-Rad, Mississauga, ON, Can-
ada). Results are expressed as a ratio (protein of interest/
β -actin) to correct for loading for each endometrial
sample.Reproductive Biology and Endocrinology 2005, 3:20 http://www.rbej.com/content/3/1/20
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Hoechst and trypan blue exclusion staining
Following TGF-β  treatment, both floating and attached
cells were resuspended in PBS containing Hoechst 33258
for 24 hours at 4°C or resuspended in trypan blue solu-
tion (0,4%) for 5 minutes. Hoechst nuclear staining was
viewed and photographed using a Olympus BX60 fluores-
cence microscope and a Coolsnap-Pro CF digital Camera
(Carsen Group, ON, Canada). Cells with typical apoptotic
nuclear morphology (nuclear shrinkage, condensation
and fragmentation) were identified and counted using
randomly selected fields on numbered photographic
slides, of which the "counter" was not aware of the treat-
ment, so as to avoid experimental bias. A minimum of
200 cells per treatment group were counted in each exper-
iment. For trypan blue exclusion test, blue cells were
counted under a regular microscope and were counted as
non-living cells.
Statistical analysis
Western analyses of pregnant animals were repeated six to
eight times (6 to 8 different endometrial extract per day of
pregnancy from 6 to 8 different rats). Endometrial extracts
from each rat were assessed individually. Western analyses
of cultured decidual cells were repeated 5 times for each
TGF-β  dose (for each culture experiment, decidual cells
were recovered from a pool of ten different ovariect-
omized/treated rats). Results subjected to statistical analy-
ses were expressed as mean ± SEM. Data were subjected to
one-way ANOVA (PRISM software version 4.0; GraphPad,
San Diego, CA). Differences between experimental groups
were determined by the Tukey's test.
Results
Apoptosis expression during pregnancy
In order to confirm the presence of apoptosis in DB, the
presence of the activated form of caspase-3 was measured
by Western analysis (Fig. 1A) and immunofluorescence
(Fig. 1B) using a day 14 pregnant uterine section. TUNEL
measurement was also performed using a day 14 pregnant
uterine section (Fig. 1C). As demonstrated by Western
analysis, Fig. 1A clearly demonstrates that apoptosis was
present in the endometrium at day 14: the 17 KDa cleaved
caspase-3 fragment was significantly and gradually
increased from day 8 and was maximal at day 14. Cleaved
caspase-3 fragment was observed in the cytoplasm of
apoptotic cells as demonstrated by immunofluorescence
(Fig. 1B) and TUNEL positive cells were also found in the
in the endometrium at day 14 (Fig. 1C).
Expression of TGF-β 1, β 2 and β 3 in the rat uterus during 
pregnancy
To document the presence and expression of TGF-β  pro-
teins in the uterus throughout pregnancy, IHC and West-
ern analyses were performed on uterine sections and
lysate of pregnant rats respectively. It was important to
document the presence of TGF-β  proteins since the infor-
mation found in the literature shows principally mRNA
expression of different TGF-β  isoforms in specific periods
of pregnancy rather than in the whole gestation period.
Western blot analyses shown in figure 2 demonstrate that
TGF-β 1 and β 2 are both expressed in a similar pattern.
Their expression is increased following implantation
(days 5.5 to 6.5) and is maximal during regression of the
DB (day 14; p < 0.01). However, the localization of the
expression of those two isoforms during pregnancy is
slightly different (Fig. 3 and 4 respectively): immunohis-
tochemicals analysis confirms that during early pregnancy
the signal is found in both epithelial and stromal cells, but
during late pregnancy TGF-β 1 is expressed mainly in stro-
mal cells while TGF-β 2 is located in epithelial cells. It is
interesting to see that both TGF-β 1 and β 2 isoforms are
clearly present in the epithelial cells and in stroma at the
time of implantation (day 5.5) all around the uterine
lumen surrounding the implanting conceptus. On the
opposite, TGF-β 3 has not been found during early preg-
nancy (Fig. 2 and 5). However, TGF-β 3 was increased and
present at the time of DB regression (days 12 to 16; p <
0.001) suggesting that its action might be limited to
decidual regression during pregnancy.
Expression of Smad2 and Phospho-Smad2 during 
pregnancy
TGF-β  signal transduction is mediated intracellularly by
Smad proteins, including the R-Smads (receptor regulated
Smads including Smad2), the I-Smads (inhibitor Smads),
and the Co-Smad (common Smad). The triggering event
in Smad activation is the type I receptor-dependent
sequential phosphorylation of the two C-terminal serine
residues in Smads [29]. Therefore, phosphorylation of the
C-terminus of receptor-activated Smads, particularly
Smad2, is crucial for initiation of the TGF-β  signaling.
Western blot analyses of Smad2 and phospho-Smad2 on
endometrial cell lysate from pregnant rats were carried out
to confirm that TGF-β  isoforms present in the
endometrium during pregnancy have an activity on those
cells. The results demonstrate that Smad2 expression is
regulated throughout pregnancy (Figure 6). Its expression
is high from day 5 to 10 and is dramatically reduced from
day 12 to the end of pregnancy (p < 0.05). However the
levels of phospho-Smad2, the activated form, are high on
days 12 and 14 and are gradually reduced to the end of
pregnancy. The presence of high levels of phospho-Smad2
correlates with the high expression of the three TGF-β  iso-
forms and the presence of apoptosis, with an exception on
day 2 of pregnancy (Figure 6). Although high levels of
phospho-Smad2 are observed, levels of TGF-β 1 and -2 iso-
forms are higher when compared to days 4 and 5 and cas-
pase-3 cleaved fragment is also present.Reproductive Biology and Endocrinology 2005, 3:20 http://www.rbej.com/content/3/1/20
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Detection of apoptosis in pregnant endometrial tissues as demonstrated by Western and TUNEL analyses Figure 1
Detection of apoptosis in pregnant endometrial tissues as demonstrated by Western and TUNEL analyses. A) Apoptosis as 
determined by Western analysis of cleaved caspase-3 (one blot presented out of 6). β -actin blots shown were used as controls 
to correct for loading in each lane. Blots shown are from one representative experiment. Graphics represent Western blot 
densitometrical analysis of the 17 KDa cleaved fragment. B) Cleaved caspase-3 immunofluorescence at day 14 of pregnancy. 
Magnification: control: 10× ; inset and Day 14: 40×. C) TUNEL analysis at day 14 of pregnancy. B) and C) One representative 
section is presented out of 6 experiments. C-: negative control. Magnification: control: 10× ; inset and Day 14: 40×. Arrows 
indicate positive staining.
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TGF-β 1, -β 2 and -β 3 expressions in rat endometrium during rat pregnancy Figure 2
TGF-β 1, -β 2 and -β 3 expressions in rat endometrium during rat pregnancy. Total endometrial proteins were collected at dif-
ferent days of pregnancy. β -actin blots shown were used as controls to correct for loading in each lane. Blots shown are from 
one representative experiment. Graphics represent Western blot densitometrical analysis. Data represent the mean ± SEM of 
six independent experiments (six different rats). C+: positive control (day 14 endometrial protein extract).
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Immunohistochemistry of TGF-β 1 in rat endometrium during pregnancy Figure 3
Immunohistochemistry of TGF-β 1 in rat endometrium during pregnancy. IHC shown are from one representative experiment 
and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of 
pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: day 14; F: negative control in which primary antibody 
was absent). le: luminal epithelium; em: embryo; s: stroma. Magnification: 40×.
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Immunohistochemistry of TGF-β 2 in rat endometrium during pregnancy Figure 4
Immunohistochemistry of TGF-β 2 in rat endometrium during pregnancy. IHC shown are from one representative experiment 
and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of 
pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: day 14; F: negative control in which primary antibody 
was absent). le: luminal epithelium; em: embryo; s: stroma. Magnification: 40×.
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Immunohistochemistry of TGF-β 3 in rat endometrium during pregnancy Figure 5
Immunohistochemistry of TGF-β 3 in rat endometrium during pregnancy. IHC shown are from one representative experiment 
and were repeated 6 times using 6 different uterine sections from 6 different rats per of day pregnancy. Representative days of 
pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: day 14; F: negative control in which primary antibody 
was absent). le: luminal epithelium; em: embryo; s: stroma. Magnification: 40×.
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TGF-β  action in vitro on decidual endometrial stromal cell 
fate
As demonstrated previously by Moulton in 1994 [7], TGF-
β 1 induces DNA cleavage in rat decidual cells. To confirm
that TGF-β 1 is responsible for the induction of apoptosis,
three different techniques were used to measure apoptosis
(Figure 7). Hoechst nuclear staining (Figure 7A) and
TUNEL analysis (Figure 7C) clearly demonstrated that
TGF-β 1 induced apoptosis in a dose-dependent manner
(p < 0.0001). Apoptosis was increased to 20% at 1 ng/ml
of TGF-β 1 and up to 30% at 10 ng/ml. Trypan Blue exclu-
sion staining assay was used to test for viability and cell
death; even though this test is not an apoptotic specific
test, it shows a direct effect of TGF-β 1 on cell survival and
viability. A dose-dependent increase of cell death was
observed in response to TGF-β 1 treatment (Figure 7B).
Smad2 and phospho-Smad2 (P-Smad2) expressions in rat endometrium during pregnancy Figure 6
Smad2 and phospho-Smad2 (P-Smad2) expressions in rat endometrium during pregnancy. Total endometrial proteins were 
collected at different days of pregnancy. β -actin blots shown were used as controls to correct for loading in each lane. Blots 
shown are from one representative experiment. Graphics represent Western blot densitometrical analysis. Data represent the 
mean ± SEM of six independent experiments (six different rats).
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Effect of TFG-β  on Akt, P-Akt, CDC-47 and XIAP 
expression in vitro on decidual endometrial stromal cells
To further determine how TGF-β  might act at the intra-cel-
lular level to induce apoptosis in decidual cells, experi-
ments were carried out to determine the possible
interaction of TGF-β  and the PI3K/Akt survival pathway.
Recent studies have suggested and demonstrated that
TGF-β  directly acts with Smad3 to regulate the sensitivity
to TGF-β  induced apoptosis [30,31] and another study
showed that TGF-β  exerts a largely inhibitory effect on
basal meningioma proliferation possibly through Smad
2/3 [32]. Since Smad3 is directly involved in TGF-β  sign-
aling, a similar mechanism might be involved in the con-
trol of decidual cell fate. Another study has shown that Akt
activity might in turn be affected by the presence or
absence of inhibitor of apoptosis proteins such as XIAP
[33,34]. Figure 8 shows that Phospho-Smad2, the acti-
vated form, is significantly increased in response to TGF-
Effect of TGF-β 1 (ng/ml) on cell survival in cultured rat endometrial cells as demonstrated by Hoechst staining, TUNEL and  trypan blue exclusion analyses Figure 7
Effect of TGF-β 1 (ng/ml) on cell survival in cultured rat endometrial cells as demonstrated by Hoechst staining, TUNEL and 
trypan blue exclusion analyses. A) Apoptosis as determined by Hoechst nuclear staining. Data represent the mean ± SEM of six 
independent experiments. All doses are significantly different from control (p < 0.001). B) Cell viability as determined by trypan 
blue exclusion assay. Data represent the mean ± SEM of six independent experiments. 1, 5 and 10 ng/ml TGF-β 1 doses are sig-
nificantly different from control (p < 0.0001). C) Apoptosis as determined by TUNEL assay. Representative fields are presented 
out of 6 experiments. Arrows indicate positive staining.
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β 1. However, the concentration-response relationship in
term of Smad phosphorylation appears to be biphasic,
with 1 ng/ml stimulating, while 10 ng/ml having a signif-
icant effect compared to control (p < 0.05) but lower than
the 1 ng/ml dose. There was no significant difference
observed in term of Smad2 protein expression in response
Expression of Smad2, P-Smad2 and CDC47 in cultured rat endometrial cells in vitro as demonstrated by Western blot analyses  in response to TGF-β 1 (ng/ml) Figure 8
Expression of Smad2, P-Smad2 and CDC47 in cultured rat endometrial cells in vitro as demonstrated by Western blot analyses 
in response to TGF-β 1 (ng/ml). β -actin blots shown were used as controls to correct for loading in each lane. Blots shown are 
from one representative experiment. Graphics represent Western blot densitometrical analysis and are the mean ± SEM of 
four independent experiments. *Significantly different from control (p < 0.05).
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Expression of Akt, P-Akt and XIAP in cultured rat endometrial cells in vitro as demonstrated by Western blot analyses in  response to TGF-β 1(νγ /µλ ) Figure 9
Expression of Akt, P-Akt and XIAP in cultured rat endometrial cells in vitro as demonstrated by Western blot analyses in 
response to TGF-β 1(νγ /µλ ). β -actin blots shown were used as controls to correct for loading in each lane. Blots shown are 
from one representative experiment. Graphics represent Western blot densitometrical analysis and are the mean ± SEM of 
four independent experiments. *Significantly different from control (p < 0.05).
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to TGF-β 1. As demonstrated in Figure 8, the proliferation
marker CDC-47 was significantly decreased in response to
TGF-β 1 treatment. Figure 9 demonstrates that Phospho-
Akt, the active form of Akt, was highly expressed in control
cells, indicating that this pathway is active and important
in cell proliferation and cell survival. However, in the
presence of TGF-β 1, Phospho-Akt was significantly
decreased suggesting an interaction of TGF-β  and the
PI3K/Akt survival pathway. Total Akt protein expression
was not influenced by TGF-β 1 treatment. Moreover, XIAP
protein expression, a well known inhibitor of apoptosis
protein, was significantly reduced in response to increas-
ing doses of TGF-β .
Discussion
Transforming growth factor-β  isoforms have been known
to be expressed and regulated differently in several types
of tissues such as ovine uterus [35], human colon carci-
noma [36] and at the porcine conceptus-maternal inter-
face [19]. They are also recognized as pro-apoptotic
factors in many cell types including fetal rat hepatocytes
[14] and human leiomyoma smooth muscle cells [37].
However, little is known about the role of TGF-β  isoforms
in the rat uterus during pregnancy. The aim of the present
study was to investigate the pro-apoptotic functions of
TGF-β  isoforms in rat uterus during pregnancy and also to
determine more precisely the different patterns of expres-
sion of those isoforms in pregnant endometrium. The
results presented in this study demonstrate that, as
observed in other tissues, TGF-β  isoforms (β 1, β 2 and β 3)
are differently regulated in rat uterus throughout
pregnancy.
It is already known that apoptosis is induced during
embryo implantation and decidualization in rodents
[1,2,7]. Our results confirm that apoptosis is induced in
the pregnant rat uterus especially during regression of the
decidua basalis. Caspases are well known executioners of
apoptosis [15,38]. The highest concentration of cleaved
caspase-3 protein, the activated form of caspase-3, was
found on day 14 of pregnancy, at the time of DB regres-
sion. The presence of active caspase-3 shows that this
pathway might be important to induce cleavage of critical
survival proteins and to further stimulate apoptosis dur-
ing the regression of DB. However, caspase-3 activation
was weakly observed at the time of implantation and this
might be explained by the fact that, although uterine epi-
thelium undergoes degeneration in the presence of
embryo [4-6], only some epithelial cells undergo apopto-
sis during this process at the implantation site. Western
blot and IHC analyses might not be sensitive enough
techniques to detect the presence of small levels of cleaved
caspase-3 in epithelial cells at implantation. It is also a
possibility that degeneration of the epithelium may also
involve non-apoptotic pathways.
The logical pursuit of this study was to determine the
expression of TGF-β  isoforms during those critical stages
of pregnancy. The present results are consistent with pre-
vious work published in regards to TGF-β  isoforms in
other systems and in mouse uterus [18,22,39], where
expression and regulation is different for each isoform.
TGF-β 1 was already known to induce apoptosis in human
[40] and rat [7] endometrial stromal cells. In the present
study, TGF-β 1 and TGF-β 2 were found throughout preg-
nancy and were particularly strong during apoptotic
phases such as regression of the DB. On the other hand,
using both IHC and Western analyses, TGF-β 3 protein was
undetectable in the early stages of gestation, suggesting
that TGF-β 3 may not be required in the regulation of cell
death during embryo implantation and early pregnancy.
This result supports a study performed by Das et al. [18]
showing that TGF-β 3 mRNA was absent during early
pregnancy. Nevertheless, the three mammalian forms of
TGF-β  are strongly expressed during regression of the DB
suggesting they could all play an important role during
the regulation of programmed cell death to induced
regression of DB. Those three isoforms are also expressed
differently in distinct cells of the same tissues; similarities
have been observed in human normal and malignant
prostate epithelial cells [39] as TGF-β 2 and TGF-β 3 are
more expressed in epithelial cells than in stromal cells
during late pregnancy. The strong expression of TGF-β 1
during rat early pregnancy (day 5.5 to 6.5) may be
explained by the fact that this isoform could be necessary
to initiate embryo implantation processes during the per-
iimplantation period, a similar situation that is observed
during trophoblast invasion at the time of human embryo
implantation [41].
The next logical step of the present study was to determine
if the TGF-β  isoforms present during pregnancy were
active. A lot of information can be found in many physio-
logical systems regarding TGF-β  and its cellular receptors
[8,10] and Smad proteins responsible for its intracellular
signal transduction [42-44]. Recent studies have suggested
and demonstrated that TGF-β  directly acts with Smad3 to
regulate the sensitivity to TGF-β  induced apoptosis
[30,31] and another study showed that TGF-β  exerts a
largely inhibitory effect on basal meningioma prolifera-
tion possibly through Smad 2/3 [32]. Since Smad3 is
directly involved in TGF-β  signaling, a similar mechanism
might be involved in the control of decidual cell fate.
Since it is well known that TGF-β  signals through Smads
proteins, Western blot and IHC analyses were performed
on pregnant endometrial cell lysates to measure Smad2
and phospho-Smad2 (the activated form) to test this
hypothesis. The results showed that Smad2 protein was
increased and stronger at the time of embryo implanta-
tion and that Smad2 phosphorylation was gradually
increased during regression of the DB, which correlatesReproductive Biology and Endocrinology 2005, 3:20 http://www.rbej.com/content/3/1/20
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with the presence of TGF-β  isoforms. These results suggest
that TGF-β  isoforms present during these two critical
stages of pregnancy might act through Smads proteins to
induce apoptosis or to induce other genes known to be
regulated by TGF-β s. Smad2 protein is relatively low dur-
ing regression of the DB compared to early stages of preg-
nancy. This result is supported by a recent study showing
that increased Smad2 expression is probably caused by
the invasion of the trophoblast resulting in the formation
of the first decidual zone [45]. However, Smad2 phospho-
rylation is not as much increased during early pregnancy
as compared to late pregnancy. It is again a possibility
that, since only epithelial cells undergo apoptosis at the
time of embryo implantation, the possible increase of
Smad2 phosphorylation induced by TGF-β  might only be
observed in a small number of cells which was undetecta-
ble with the techniques used.
To better understand the effect of TGF-β  at the cellular
level, decidual cell cultures were used to further investi-
gate the interaction of TGF-β  and the PI 3-K/Akt survival
pathway. Although a recent study showed the possibility
that cells obtained following artificial decidualization
might be different from those obtained from pregnant
animals [46], this model is an excellent alternative to
obtain sufficient material to test the role of TGF-β  and to
correlates the data with the physiologic situation. It has
been demonstrated recently that Akt phosphorylation is
directly induced by 17β -estradiol in the ovariectomized
rat uterus indicating that sex steroids have an important
influence on endometrial cell fate [47]. Very recent studies
have shown that TGF-β  might directly block Akt activity
through Smad activation [30]. Thus, stromal decidual
cells were treated with different doses of TGF-β 1 to deter-
mine if Smad activation might in turn block Akt survival
pathway to induce cell death. TGF-β 1 induced Smad2
phosphorylation in cultured endometrial stromal cell in
vitro and triggered apoptosis in a dose-dependent manner,
which was accompanied by a reduction of cell prolifera-
tion, confirming TGF-β  as an apoptotic factor in rat decid-
ual endometrial stromal cells. In response to TGF-β 1, Akt
phosphorylation was significantly decreased indicating
that Akt activity inhibition might be an important mech-
anism for TGF-β -induced apoptosis in this model. Other
studies have shown that Akt activity might in turn be
affected by the presence or absence of inhibitor of apop-
tosis proteins such as XIAP [33,34] and cIAP-1 [48]. The
results support the hypothesis that TGF-β  action via
Smads not only acts at the transcriptional level to induce
production of apoptotic factors in decidual cells but also
at the protein level to block activation of survival factors.
Akt phosphorylation was recently shown to be regulated
by XIAP, a well known inhibitor of apoptosis protein, in
human ovarian epithelial surface cells and in rat granu-
losa cells [33,34]. The present results show a possible
interaction (direct or indirect) between TGF-β 1 and XIAP
protein expression. TGF-β 1 reduced XIAP expression in
vitro in a dose dependent manner. Recent studies have
demonstrated that XIAP can act as a cofactor in the regu-
lation of gene expression induced by TGF-β  and is
independent of Smad4 [14,49]. Because TGF-β 1 reduced
Akt phosphorylation and that XIAP was shown to induce
Akt phosphorylation [34], it is possible that TGF-β  action
in this case might be through Smad2 activation and XIAP
gene expression which in turn would act on Akt phospho-
rylation. Further experiments will be necessary to have a
better understanding of the interactions between TGF-β
and Akt survival pathway. In particular, how specifically
Smads act on XIAP expression and how XIAP acts on the
PI 3-K/Akt survival pathway activity. Other factors such as
Smac/Diablo, a XIAP intracellular inhibitor, which was
demonstrated as being regulated by 17β -estradiol in the
rat during estrous cycle [50], might also be a putative can-
didate for regulation of TGF-β  activity in decidual cells.
Conclusion
In conclusion, this study demonstrates that the three iso-
forms of TGF-β  are differently localized and regulated in
endometrial cells of pregnant rats, particularly at the time
of implantation and regression of the DB. The present
study also showed that TGF-β  plays an important role in
the control of cell survival and cell death and that it may
interacts with the PI 3-K/Akt survival pathway through
Smad activation to allow apoptosis induction. Further
experiments will be necessary to understand more pre-
cisely the effect of other Smads and/or co-Smads proteins
during TGF-β -induced apoptosis. Other investigations
will also be required to better understand the specific roles
of TGF-β 2 and TGF-β 3 at the intracellular and molecular
level in vitro to determine how and if these isoforms con-
trol cell survival through Smad signal transducers.
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